Effects of introducing Xpert MTB/RIF test on multi-drug resistant tuberculosis diagnosis in KwaZulu-Natal South Africa

BACKGROUND: An algorithm instituted following Xpert MTB/RIF (Xpert) introduction in South Africa advocates for treating all Xpert rifampicin resistant patients as MDR-TB cases while awaiting confirmation by phenotypic or genotypic drug susceptibility testing. This study evaluates how the Xpert has i...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Dlamini-Mvelase, Nomonde R, Werner, Lise, Phili, Rogerio, Cele, Lindiwe P, Mlisana, Koleka P
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2014
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4141089/
https://ncbi.nlm.nih.gov/pubmed/25129689
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2334-14-442
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky